Primary Care Clinics in Lancaster, WI Accepting Medicare
6 Primary Care Clinics found. Showing 1 - 6
 Family Medical Center Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 9177 Old Potosi Rd, Lancaster, WI 53813 Phone: 608-723-4300 Fax: 608-723-7885 |
Physician Management Services Of Wisconsin, Llc Family Medicine Medicare: Medicare Enrolled Practice Location: 105 E Lincoln Ave, Lancaster, WI 53813 Phone: 888-829-8550 |
Grant Regional Community Clinic Family Medicine Medicare: Medicare Enrolled Practice Location: 507 S Monroe St, Lancaster, WI 53813 Phone: 608-723-2131 Fax: 608-723-4464 |
Grant Regional Community Clinic Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 507 S Monroe St, Lancaster, WI 53813 Phone: 608-723-2131 Fax: 608-723-4464 |
High Point Family Medicine, Llc Family Medicine Medicare: Medicare Enrolled Practice Location: 105 E Lincoln Ave, Lancaster, WI 53813 Phone: 608-723-3100 Fax: 866-560-8783 |
Grant Regional Family Practice Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 507 S Monroe St, Lancaster, WI 53813 Phone: 608-723-3293 Fax: 608-723-3281 |
News Archive
NIBIB-funded researcher develops new technique for tissue analysis
An NIBIB-funded researcher has developed a new technique that creates digital pictures of a tissue's chemical composition using light and a computer. The technique replaces the need for dyes or stains, which can be costly and require significant time and effort to apply.
Researchers find new innate immunity pathway that protects mammals from viral oncogenesis
Building upon earlier research, investigators at UT Southwestern Medical Center and their collaborators have identified a new innate immunity pathway that protects mammals from viral oncogenesis, the process by which viruses cause normal cells to become cancerous.
Combination therapy can reduce recurrence of small, HER2-positive breast tumors
In a phase 2 clinical trial, women with small (stage 1), HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted drug following surgery were highly unlikely to have the cancer recur within three years of treatment, investigators at Dana-Farber Cancer Institute and other institutions report in a paper published today by the New England Journal of Medicine.
Expert discusses how to identify, support individuals with drug or alcohol addiction in workplace
As businesses in the UK become more aware of the impact that alcohol and drugs have on safety and productivity in the workplace, many have implemented professional procedures for testing employees for both substances.
› Verified 6 days ago